RTI Surgical, a contract development and manufacturing organization for regenerative medicine, rebranded to Evergen.
The rebrand comes on the heels of the company acquiring Cook Biotech and Collagen Solutions. Evergen is the industry's only CDMO to offer a comprehensive portfolio of allograft and xenograft biologics, according to a Dec. 17 news release.
Evergen's regenerative medicine portfolio includes products for orthopedics, neurosurgery and sports medicine.